The debate around the usage of CBD and other hemp derivatives in cosmetic products continues to be remarkably alive at the EU level. Indeed, it seems that the November 2020 Court of Justice of the European Union (CJEU) decision in the Kanavape case – stating that CBD should no longer be regarded as a narcotic drug within the meaning of the Single Convention on Narcotic Drugs of 1961 – has paved the way for a reconsideration of the EU Cosmetic Products Regulation (CPR) that is currently in force.

This report seeks to outline the substance of the discussion at the EU level about the use of CBD and other hemp ingredients in cosmetic products, gleaned from documents CBD-Intel has obtained from EU authorities that show input provided by some member states on the matter, as requested by the European Commission (EC).

Free Sample

Table of contents

  1. Overview
  2. A walk through the process
  3. Preliminary view of the EC and feedback from member states
  4. What to expect in the future

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information


Visit store

Check out our reports
available for purchase


Get a free sample of this report:

“ EU CBD cosmetics regulation: updates on EU and member state positions ”

    Buy report request information:

    “ EU CBD cosmetics regulation: updates on EU and member state positions ”

      Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.